COVID Sponsorship with fever monitor

This short article presents greenteg’s solution supported by COVID Sponsorship for fever monitoring: core body temperature monitoring solution for fever detection and remote patient monitoring.

About greenteg’s COVID Sponsorship with fever monitor

Zurich, March 23rd, 2020

The current COVID-19 global pandemic raises many challenges for individuals, companies, and governments. As the disease has spread to well nearly 200 countries, the devastating health and socio-economic impact of the pandemic becomes evident. Consequently, these developments have sparked wide-scale initiatives by companies and individuals to develop new tools like vaccines, protective equipment, or monitoring solutions to assist in the battle of this unexpected crisis.

Fever is the most common initial symptom [1] of the virus and this is where greenteg wants to help. Our non-invasive and continuous core body temperature monitoring patch enables early fever detection using only skin contact. The accuracy of the device has been verified in multiple clinical studies.

We believe that our solution can reduce the strain on the healthcare system by monitoring healthcare professionals exposed to the virus and by furthermore monitoring general ward patients, thus freeing up precious nursing resources. The device can further be effective for scientists researching the influence of the novel Coronavirus on the body temperature (e.g. temperature patterns).

greenteg is offering its expertise and its technology as a contribution to overcome the current Corona crisis faster and with less sacrifice. greenteg is willing to sponsor sensors for selected medical research on Covid-19 patients or health care professionals. At the same time greenteg is looking for partners capable of bringing its continuous and non-invasive core body temperature monitoring solution to the market as quickly as possible. Interested researchers or clinicians as well as potential commercialization partners, please contact us at hendrichs@greenteg.com.

[1] 98.6% of patients showed fever at onset of a diagnosed Covid-19 infection according to Wang D, 07.02.2020: Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia